Need to optimize drug design? COOKIE-Pro can help.
With COOKIE-Pro drug designers can see for the first time not just if a drug binds off-target, but how well and how fast.
Read More
With COOKIE-Pro drug designers can see for the first time not just if a drug binds off-target, but how well and how fast.
Read MoreThe funding is to renew the Brittle Bone Disorders Consortium for five years and to launch the Rare Organic Acidemias Research Consortium.
Read MoreThe collaboration to develop novel small-molecule drugs allows for the fine-tuning of immune responses in multiple diseases.
Read MoreThe results suggest the exciting possibility of targeting this newly discovered mechanism for weight management.
Read MoreThe findings bring us one step closer to improving ER+ breast cancer patients’ response to therapy.
Read MoreThe findings open new possibilities for future treatments to prevent or treat the condition.
Read MoreDr. Felipe Andrés Piedra shares with a student from BCM Biotech Academy at Rusk his work training bacteria to eat plastic, aiding in the effort to create a cleaner, healthier world.
Read MoreThe new AI tool, called DeepMVP, significantly outperforms previously published models and has implications for the development of novel therapeutics.
Read MoreTheir findings suggest that smells play a more complex role in feeding behavior and regulation of food intake than was previously understood.
Read MoreThe findings show that diet interacts with an individual’s genetic makeup, influencing daily patterns of gene activity in the liver, especially those related to fat metabolism.
Read More